MD Stem Cells is the sponsor of specialty clinical studies involving ophthalmology, neurology and spinal cord injury. Our success stems from years of effort first in Europe and, beginning in 2013, with US based, FDA compliant, IRB approved and NIH registered studies. MD Stem Cells provides the only stem cell treatments in ophthalmology with medical journal published, statistically significant results. That means eligible patients can enroll in a study with scientifically proven results right now. We use only adult, bone marrow derived stem cells – never adipose, fat, or embryonic derived cells. Our proprietary approaches maximize yield and effectiveness. With hundreds of patients having participated and significant numbers having meaningful improvements, we hope you take a careful look at our experience and results.